Dynatronics Corporation (DYNT)
USD 0.13
(10.23%)
USD 0.13
(10.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 11.78 Million USD | -10.8% |
| 2023 | 13.2 Million USD | -3.85% |
| 2022 | 13.73 Million USD | 0.8% |
| 2021 | 13.62 Million USD | 77.44% |
| 2020 | 7.67 Million USD | -59.32% |
| 2019 | 18.87 Million USD | -8.71% |
| 2018 | 20.67 Million USD | 50.49% |
| 2017 | 13.73 Million USD | 41.87% |
| 2016 | 9.68 Million USD | -18.24% |
| 2015 | 11.84 Million USD | 42.95% |
| 2014 | 8.28 Million USD | -6.85% |
| 2013 | 8.89 Million USD | -1.21% |
| 2012 | 9 Million USD | 9.76% |
| 2011 | 8.2 Million USD | -1.05% |
| 2010 | 8.29 Million USD | -22.28% |
| 2009 | 10.66 Million USD | -12.29% |
| 2008 | 12.16 Million USD | 62.23% |
| 2007 | 7.49 Million USD | 54.49% |
| 2006 | 4.85 Million USD | 22.97% |
| 2005 | 3.94 Million USD | -29.49% |
| 2004 | 5.59 Million USD | 9.48% |
| 2003 | 5.11 Million USD | 3.65% |
| 2002 | 4.93 Million USD | -22.13% |
| 2001 | 6.33 Million USD | 8.99% |
| 2000 | 5.81 Million USD | -18.16% |
| 1999 | 7.1 Million USD | 20.34% |
| 1998 | 5.9 Million USD | 28.26% |
| 1997 | 4.6 Million USD | 12.2% |
| 1996 | 4.1 Million USD | 41.38% |
| 1995 | 2.9 Million USD | -12.12% |
| 1994 | 3.3 Million USD | 57.14% |
| 1993 | 2.1 Million USD | 162.5% |
| 1992 | 800 Thousand USD | 33.33% |
| 1991 | 600 Thousand USD | 0.0% |
| 1990 | 600 Thousand USD | -62.5% |
| 1989 | 1.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 11.78 Million USD | -8.82% |
| 2024 Q1 | 13.8 Million USD | 4.51% |
| 2024 Q3 | 12.91 Million USD | -6.17% |
| 2024 Q2 | 13.76 Million USD | -0.24% |
| 2023 FY | 13.2 Million USD | -3.85% |
| 2023 Q1 | 13.72 Million USD | -0.05% |
| 2023 Q4 | 13.2 Million USD | -7.16% |
| 2023 Q3 | 14.22 Million USD | -2.23% |
| 2023 Q2 | 14.54 Million USD | 5.97% |
| 2022 Q1 | 13.35 Million USD | -1.99% |
| 2022 Q3 | 14.26 Million USD | 9.7% |
| 2022 Q2 | 13 Million USD | -2.61% |
| 2022 FY | 13.73 Million USD | 0.8% |
| 2022 Q4 | 13.73 Million USD | -3.74% |
| 2021 Q2 | 18.61 Million USD | 8.29% |
| 2021 FY | 13.62 Million USD | 77.44% |
| 2021 Q1 | 17.18 Million USD | 123.83% |
| 2021 Q3 | 17.36 Million USD | -6.72% |
| 2021 Q4 | 13.62 Million USD | -21.52% |
| 2020 Q2 | 21.09 Million USD | -1.71% |
| 2020 Q1 | 21.45 Million USD | 13.68% |
| 2020 Q3 | 22.18 Million USD | 5.18% |
| 2020 Q4 | 7.67 Million USD | -65.39% |
| 2020 FY | 7.67 Million USD | -59.32% |
| 2019 Q3 | 18.42 Million USD | 6.48% |
| 2019 Q4 | 18.87 Million USD | 2.47% |
| 2019 FY | 18.87 Million USD | -8.71% |
| 2019 Q1 | 19.29 Million USD | -6.68% |
| 2019 Q2 | 17.3 Million USD | -10.34% |
| 2018 Q4 | 20.67 Million USD | -3.45% |
| 2018 FY | 20.67 Million USD | 50.49% |
| 2018 Q1 | 19.15 Million USD | 39.4% |
| 2018 Q3 | 21.41 Million USD | -4.47% |
| 2018 Q2 | 22.41 Million USD | 17.05% |
| 2017 Q4 | 13.73 Million USD | 14.49% |
| 2017 FY | 13.73 Million USD | 41.87% |
| 2017 Q1 | 9.93 Million USD | 2.55% |
| 2017 Q2 | 10.12 Million USD | 1.9% |
| 2017 Q3 | 12 Million USD | 18.58% |
| 2016 Q4 | 9.68 Million USD | 8.11% |
| 2016 FY | 9.68 Million USD | -18.24% |
| 2016 Q3 | 8.95 Million USD | -9.11% |
| 2016 Q2 | 9.85 Million USD | -1.31% |
| 2016 Q1 | 9.98 Million USD | -15.69% |
| 2015 Q3 | 12.24 Million USD | 4.41% |
| 2015 Q1 | 12.2 Million USD | 47.33% |
| 2015 Q2 | 11.72 Million USD | -3.95% |
| 2015 FY | 11.84 Million USD | 42.95% |
| 2015 Q4 | 11.84 Million USD | -3.25% |
| 2014 Q1 | 8.78 Million USD | -1.29% |
| 2014 Q4 | 8.28 Million USD | -1.07% |
| 2014 Q2 | 8.95 Million USD | 1.97% |
| 2014 Q3 | 8.37 Million USD | -6.45% |
| 2014 FY | 8.28 Million USD | -6.85% |
| 2013 Q2 | 8.96 Million USD | -0.38% |
| 2013 Q4 | 8.89 Million USD | 2.64% |
| 2013 Q3 | 8.66 Million USD | -3.31% |
| 2013 FY | 8.89 Million USD | -1.21% |
| 2013 Q1 | 8.99 Million USD | -0.07% |
| 2012 Q1 | 8.87 Million USD | 8.23% |
| 2012 Q3 | 9.17 Million USD | 5.6% |
| 2012 FY | 9 Million USD | 9.76% |
| 2012 Q4 | 9 Million USD | -1.88% |
| 2012 Q2 | 8.68 Million USD | -2.13% |
| 2011 FY | 8.2 Million USD | -1.05% |
| 2011 Q4 | 8.2 Million USD | 1.35% |
| 2011 Q3 | 8.09 Million USD | 0.31% |
| 2011 Q2 | 8.06 Million USD | -1.78% |
| 2011 Q1 | 8.21 Million USD | -0.9% |
| 2010 Q1 | 10.91 Million USD | 2.35% |
| 2010 FY | 8.29 Million USD | -22.28% |
| 2010 Q4 | 8.29 Million USD | -16.14% |
| 2010 Q3 | 9.88 Million USD | 0.73% |
| 2010 Q2 | 9.81 Million USD | -10.11% |
| 2009 FY | 10.66 Million USD | -12.29% |
| 2009 Q1 | 12.54 Million USD | 3.18% |
| 2009 Q4 | 10.66 Million USD | -4.63% |
| 2009 Q2 | 13.13 Million USD | 4.64% |
| 2009 Q3 | 11.18 Million USD | -14.81% |
| 2008 Q2 | 12.53 Million USD | 9.88% |
| 2008 Q3 | 12.98 Million USD | 3.62% |
| 2008 FY | 12.16 Million USD | 62.23% |
| 2008 Q4 | 12.16 Million USD | -6.33% |
| 2008 Q1 | 11.4 Million USD | 52.12% |
| 2007 Q1 | 5.04 Million USD | 3.95% |
| 2007 FY | 7.49 Million USD | 54.49% |
| 2007 Q4 | 7.49 Million USD | 40.87% |
| 2007 Q3 | 5.32 Million USD | 9.66% |
| 2007 Q2 | 4.85 Million USD | -3.8% |
| 2006 FY | 4.85 Million USD | 22.97% |
| 2006 Q1 | 4.06 Million USD | 3.06% |
| 2006 Q2 | 4.63 Million USD | 14.03% |
| 2006 Q3 | 5.49 Million USD | 18.55% |
| 2006 Q4 | 4.85 Million USD | -11.73% |
| 2005 Q4 | 3.94 Million USD | -15.41% |
| 2005 FY | 3.94 Million USD | -29.49% |
| 2005 Q1 | 5.35 Million USD | -4.35% |
| 2005 Q2 | 4.93 Million USD | -7.74% |
| 2005 Q3 | 4.66 Million USD | -5.54% |
| 2004 Q3 | 5.88 Million USD | 3.44% |
| 2004 Q2 | 5.68 Million USD | 0.23% |
| 2004 Q1 | 5.67 Million USD | 10.96% |
| 2004 Q4 | 5.59 Million USD | -4.83% |
| 2004 FY | 5.59 Million USD | 9.48% |
| 2003 FY | 5.11 Million USD | 3.65% |
| 2003 Q1 | 5.14 Million USD | 4.37% |
| 2003 Q3 | 5.16 Million USD | 4.48% |
| 2003 Q2 | 4.94 Million USD | -3.95% |
| 2003 Q4 | 5.11 Million USD | -1.05% |
| 2002 Q2 | 6.38 Million USD | -8.49% |
| 2002 FY | 4.93 Million USD | -22.13% |
| 2002 Q4 | 4.93 Million USD | -17.46% |
| 2002 Q3 | 5.97 Million USD | -6.4% |
| 2002 Q1 | 6.97 Million USD | 10.14% |
| 2001 Q3 | 6.19 Million USD | 14.25% |
| 2001 FY | 6.33 Million USD | 8.99% |
| 2001 Q1 | 5.76 Million USD | -0.85% |
| 2001 Q2 | 5.42 Million USD | -5.86% |
| 2001 Q4 | 6.33 Million USD | 2.22% |
| 2000 FY | 5.81 Million USD | -18.16% |
| 2000 Q2 | 6.7 Million USD | -2.9% |
| 2000 Q3 | 6.37 Million USD | -4.9% |
| 2000 Q4 | 5.81 Million USD | -8.8% |
| 2000 Q1 | 6.9 Million USD | -2.82% |
| 1999 Q1 | 8.1 Million USD | 37.29% |
| 1999 Q3 | 7.1 Million USD | -2.74% |
| 1999 Q4 | 7.1 Million USD | 0.0% |
| 1999 Q2 | 7.3 Million USD | -9.88% |
| 1999 FY | 7.1 Million USD | 20.34% |
| 1998 Q2 | 4.7 Million USD | 9.3% |
| 1998 Q3 | 5.2 Million USD | 10.64% |
| 1998 Q4 | 5.9 Million USD | 13.46% |
| 1998 FY | 5.9 Million USD | 28.26% |
| 1998 Q1 | 4.3 Million USD | -6.52% |
| 1997 Q2 | 3.7 Million USD | -9.76% |
| 1997 Q4 | 4.6 Million USD | 15.0% |
| 1997 FY | 4.6 Million USD | 12.2% |
| 1997 Q1 | 4.1 Million USD | 0.0% |
| 1997 Q3 | 4 Million USD | 8.11% |
| 1996 Q3 | 3 Million USD | 0.0% |
| 1996 FY | 4.1 Million USD | 41.38% |
| 1996 Q1 | 2.9 Million USD | 0.0% |
| 1996 Q2 | 3 Million USD | 3.45% |
| 1996 Q4 | 4.1 Million USD | 36.67% |
| 1995 Q1 | 3.2 Million USD | -3.03% |
| 1995 FY | 2.9 Million USD | -12.12% |
| 1995 Q4 | 2.9 Million USD | -3.33% |
| 1995 Q3 | 3 Million USD | 0.0% |
| 1995 Q2 | 3 Million USD | -6.25% |
| 1994 Q3 | 3.1 Million USD | -6.06% |
| 1994 Q1 | 3 Million USD | 42.86% |
| 1994 Q2 | 3.3 Million USD | 10.0% |
| 1994 Q4 | 3.3 Million USD | 6.45% |
| 1994 FY | 3.3 Million USD | 57.14% |
| 1993 FY | 2.1 Million USD | 162.5% |
| 1993 Q3 | 1.7 Million USD | 88.89% |
| 1993 Q1 | 500 Thousand USD | -37.5% |
| 1993 Q2 | 900 Thousand USD | 80.0% |
| 1993 Q4 | 2.1 Million USD | 23.53% |
| 1992 Q4 | 800 Thousand USD | 0.0% |
| 1992 Q2 | 500 Thousand USD | 0.0% |
| 1992 FY | 800 Thousand USD | 33.33% |
| 1992 Q1 | 500 Thousand USD | -16.67% |
| 1992 Q3 | 800 Thousand USD | 60.0% |
| 1991 FY | 600 Thousand USD | 0.0% |
| 1991 Q2 | 500 Thousand USD | -16.67% |
| 1991 Q1 | 600 Thousand USD | 0.0% |
| 1991 Q3 | 700 Thousand USD | 40.0% |
| 1991 Q4 | 600 Thousand USD | -14.29% |
| 1990 Q3 | 800 Thousand USD | 0.0% |
| 1990 FY | 600 Thousand USD | -62.5% |
| 1990 Q4 | 600 Thousand USD | -25.0% |
| 1989 Q4 | 1.6 Million USD | 0.0% |
| 1989 FY | 1.6 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 78.519% |
| Axonics, Inc. | 82.35 Million USD | 85.697% |
| INVO Bioscience, Inc. | 19.99 Million USD | 41.085% |
| CVRx, Inc. | 39.28 Million USD | 70.011% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 94.719% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -270.218% |
| MaxCyte, Inc. | 36.1 Million USD | 67.374% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 45.178% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 90.497% |
| Sintx Technologies, Inc. | 6.59 Million USD | -78.676% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 77.016% |
| Apyx Medical Corporation | 52.31 Million USD | 77.484% |
| Cutera, Inc. | 518.12 Million USD | 97.726% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -120.519% |
| NeuroPace, Inc. | 86.99 Million USD | 86.459% |
| IRIDEX Corporation | 24.91 Million USD | 52.717% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 86.582% |
| enVVeno Medical Corporation | 2.43 Million USD | -383.783% |
| TELA Bio, Inc. | 59.16 Million USD | 80.09% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.157% |
| UFP Technologies, Inc. | 118.04 Million USD | 90.021% |
| Modular Medical, Inc. | 2.27 Million USD | -418.491% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 59.833% |
| LENSAR, Inc. | 22.4 Million USD | 47.431% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.463% |
| Surmodics, Inc. | 65.82 Million USD | 82.103% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -14.159% |
| Inogen, Inc. | 121.38 Million USD | 90.295% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -603.711% |
| RxSight, Inc. | 22.18 Million USD | 46.908% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2669.96% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 60.177% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 49.079% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2669.96% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -384.918% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 88.738% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 98.325% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 53.736% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 77.198% |
| InMode Ltd. | 75.91 Million USD | 84.482% |
| Bruker Corporation | 2.83 Billion USD | 99.585% |
| Movano Inc. | 5.97 Million USD | -97.256% |
| Orthofix Medical Inc. | 326.58 Million USD | 96.393% |
| FONAR Corporation | 57.45 Million USD | 79.498% |
| BioSig Technologies, Inc. | 4.68 Million USD | -151.443% |
| Envoy Medical, Inc. | 9.4 Million USD | -25.294% |
| Align Technology, Inc. | 2.45 Billion USD | 99.52% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 79.817% |
| Talis Biomedical Corporation | 29.22 Million USD | 59.69% |
| Cerus Corporation | 144.3 Million USD | 91.837% |
| 908 Devices Inc. | 37.49 Million USD | 68.578% |
| Nemaura Medical Inc. | 26.37 Million USD | 55.34% |
| Outset Medical, Inc. | 190.91 Million USD | 93.83% |
| NanoVibronix, Inc. | 2.68 Million USD | -338.575% |
| Venus Concept Inc. | 107.1 Million USD | 89.001% |
| Telesis Bio, Inc. | 40.87 Million USD | 71.179% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 89.664% |
| Quipt Home Medical Corp. | 136.29 Million USD | 91.357% |
| IRadimed Corporation | 20.73 Million USD | 43.19% |
| Tenon Medical, Inc. | 5.56 Million USD | -111.606% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -229.79% |
| Pulmonx Corporation | 60.63 Million USD | 80.572% |
| iCAD, Inc. | 8 Million USD | -47.233% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 7.174% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -537.483% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 71.12% |
| SI-BONE, Inc. | 61.05 Million USD | 80.704% |
| Semler Scientific, Inc. | 6.27 Million USD | -87.881% |
| Biotricity, Inc. | 35.91 Million USD | 67.204% |
| Cytosorbents Corporation | 29.98 Million USD | 60.714% |
| DexCom, Inc. | 4.19 Billion USD | 99.719% |
| ZimVie Inc. | 795.85 Million USD | 98.52% |
| Aethlon Medical, Inc. | 2.47 Million USD | -375.072% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 1.488% |
| IceCure Medical Ltd | 4.24 Million USD | -177.375% |
| PAVmed Inc | 57.13 Million USD | 79.383% |
| Sight Sciences, Inc. | 46.43 Million USD | 74.632% |
| Insulet Corporation | 1.85 Billion USD | 99.365% |
| Profound Medical Corp. | 12.66 Million USD | 6.993% |
| electroCore, Inc. | 8.94 Million USD | -31.695% |
| Bioventus Inc. | 589.79 Million USD | 98.003% |
| InspireMD, Inc. | 8.14 Million USD | -44.683% |
| PAVmed Inc. | 57.13 Million USD | 79.383% |
| Nuwellis, Inc. | 6.78 Million USD | -73.748% |
| OrthoPediatrics Corp. | 72.56 Million USD | 83.765% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 1.488% |
| BrainsWay Ltd. | 15.31 Million USD | 23.076% |
| BIOLASE, Inc. | 35.34 Million USD | 66.674% |
| Beyond Air, Inc. | 29.77 Million USD | 60.436% |
| AxoGen, Inc. | 101.16 Million USD | 88.355% |
| Inari Medical, Inc. | 209.32 Million USD | 94.372% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -438.935% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -562.176% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.626% |
| Quanterix Corporation | 78.08 Million USD | 84.914% |
| Viveve Medical, Inc. | 10.84 Million USD | -8.603% |
| LivaNova PLC | 1.15 Billion USD | 98.977% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 33.197% |
| Varex Imaging Corporation | 668.6 Million USD | 98.238% |
| Vivani Medical, Inc. | 25.03 Million USD | 52.947% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -189.865% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -229.79% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -141.149% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.872% |
| TransMedics Group, Inc. | 568.84 Million USD | 97.929% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 29.384% |
| NeuroMetrix, Inc. | 1.33 Million USD | -783.647% |
| Spectral AI, Inc. | 12.4 Million USD | 5.007% |
| Hyperfine, Inc. | 9.8 Million USD | -20.205% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 95.293% |
| Biomerica, Inc. | 2.66 Million USD | -342.363% |
| Bone Biologics Corporation | 831.4 Thousand USD | -1316.898% |
| AVITA Medical, Inc. | 19.86 Million USD | 40.7% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -496.86% |
| Silk Road Medical, Inc | 114.15 Million USD | 89.681% |